Trial Profile
A Single-center Pilot Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2016
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Astellas Pharma Korea
- 17 Nov 2016 New trial record